Recent federal legislation imposes financial penalties on hospitals that experience excessive patient readmissions within 30 days. A new study published today in the Journal of Hospital Medicine looks at the potential of a program designed to improve the discharge process and prevent avoidable rehospitalizations.
Developed by the Society of Hospital Medicine, Project BOOST (Better Outcomes by Optimizing Safe Transitions) Mentoring Program focuses on identifying patients at highest risk for readmissions, communicating discharge plans effectively, and ensuring close follow-up through phone calls and timely doctors' appointments. An integral component is the use of physician mentors to facilitate implementation of BOOST tools at participating hospitals. To assess the effectiveness of BOOST, researchers studied hospitals varying in geography, size, and academic affiliation that implemented BOOST. While 30 hospitals had implemented the program when the study was initiated, only 11 were able to provide hospital unitspecific data for the study. Notably, hospitals received no funding to participate in BOOST.
The investigators found that the average rate of 30 day rehospitalization in BOOST units was 14.7 percent prior to implementing the program and 12.7 percent twelve months later, reflecting an absolute reduction of 2 percent and a relative reduction of 13.6 percent. Rehospitalization rates for similar hospital units that did not implement BOOST were 14.0 percent in the pre-intervention period and 14.1 percent in the post-intervention period. The average absolute reduction in readmission rates in BOOST units compared with other units was 2.0 percent, or a nearly 14 percent relative reduction.
"Our findings support that among the sites willing and able to share the outcome data required for the study, there was significant improvement," sayslead BOOST analyst Luke Hansen, MD, MHS, of the Northwestern University Feinberg School of Medicine. "There is more work to do to fully engage non-academic sites in quality improvement research like ours and to understand what makes for fertile ground for implementing changes included in the BOOST toolkit."
"We are encouraged by our initial findings and learned substantially from this initial implementation and evaluation," adds BOOST principal investigator, Mark V. Williams, MD, MHM, of the Northwestern University Feinberg School of Medicine. "Subsequent Project BOOST collaboration with greater than 130 hospitals has been modified and bolstered to increase the intensity of the BOOST intervention," he said.
In an accompanying editorial, Ashish Jha, MD, MPH, of the Harvard School of Public Health, noted that the study's findings suggest only a small improvement among a very select group of hospitals. "Hospitals will need to find ways to reduce readmissions, and programs like BOOST, even when executed perfectly, will be necessary but likely insufficient. Improving the quality of care transitions is critically important. But to truly get to better outcomes for older Americans, hospitals will need to think beyond their four walls," he wrote.
In another accompanying editorial, Andrew Auerbach, MD, MPH, of the UCSF School of Medicine, and his colleagues pointed to several shortcomings, but they stated that "the authors provide the necessary start down the road towards a fuller understanding of real world efforts to reduce readmissions. The nuances and flaws of this study provide ample fodder for others working in the field."
Â
Â
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Flawed From the Start: Why Many IFUs for Surgical Instruments Fail in Real-World Sterile Processing
July 23rd 2025At the 2025 HSPA Annual Conference & Expo, Cori L. Ofstead, MSPH, highlighted critical flaws in manufacturers’ instructions for use (IFUs) for orthopedic and neurosurgical instruments. From contradictory directions to unrealistic cleaning expectations, these IFUs often fail under real-world conditions, jeopardizing both patient safety and sterile processing workflows.
US Withdrawal From UNESCO Signals a Dangerous Step Back for Global Science
July 22nd 2025In a decision heavy with consequence and light on foresight, the US has once again chosen to walk away from UNESCO, leaving behind not just a seat at the table, but a legacy of global scientific leadership that now lies in question.
Pathogen Pulse: Facilities Need the SPD, Yersinia Enterocolitica Outbreak, and More
July 22nd 2025From unsterilized surgical tools in Colorado to a years-long methicillin-resistant Staphylococcus aureus (MRSA) outbreak in Virginia and a surging measles crisis in Canada, recent headlines reveal the fragile front lines of infection prevention and the high stakes when systems fail.
Telemedicine's Transformative Role in PPE Distribution and Sterile Equipment Management
July 22nd 2025In an era defined by digital transformation and post-pandemic urgency, telemedicine has evolved beyond virtual visits to become a vital infrastructure for delivering personal protective equipment (PPE) and managing sterile supplies. By enabling real-time forecasting, remote quality control, and equitable distribution, telemedicine is revolutionizing how health care systems protect both patients and providers.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.